Brain Targeting of 1,9-Pyrazoloanthrone an c-Jun-N-terminal Kinase Inhibitor Using Liposomes for Effective Management of Parkinson’s Disease

The major challenge to treat Parkinson’s disease (PD) is penetration of target molecule into the brain to improve the efficacy of drugs. To achieve better brain penetration and targeted delivery, 1,9-Pyrazoloanthrone (1,9-P) loaded liposomes were developed by solvent injection technique using ultras...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambhore, Nilesh Sudhakar, Satyanarayana Raju, Kalidhindi Rama, Mulukutla, Shashank, Yamjala, Karthik, Mohire, Shubhashri, Satyanarayana Reddy Karri, Veera Venkata, Gupta, Saurabh, Murthy, Vishakantha, Elango, Kannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843308/
https://www.ncbi.nlm.nih.gov/pubmed/29552055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843308/
https://www.ncbi.nlm.nih.gov/pubmed/29552055

Ejemplares similares